On October 26, 2022, HCA Healthcare, Inc. filed a Current Report on Form 8-K announcing the appointment of Jon M. Foster as the Executive Vice President and Chief Operating Officer of the Company effective January 1, 2023. In accordance with Instruction 2 to Item 5.02 of Form 8-K, the Company is filing this Amendment No. 1 to the Original 8-K to provide information regarding material changes to Mr. Foster's compensation arrangements as a result of the Appointment, which arrangements had not been determined at the time of the filing of the Original 8-K. The Compensation Changes were approved by the Compensation Committee of the Company's Board of Directors on January 24, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
340.5 USD | +0.01% |
|
-0.05% | +25.79% |
06-10 | Argus Raises HCA Healthcare's Price Target to $400 From $390 | MT |
06-07 | Wolfe Research Adjusts Price Target on HCA Healthcare to $358 From $357 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.79% | 89.18B | |
-23.21% | 76.11B | |
+1.62% | 27.11B | |
-10.58% | 17.13B | |
-0.32% | 16.83B | |
+0.52% | 15.4B | |
+77.83% | 13.68B | |
+79.56% | 13.25B | |
-25.79% | 12.83B | |
+24.42% | 12.69B |
- Stock Market
- Equities
- HCA Stock
- News HCA Healthcare, Inc.
- HCA Healthcare, Inc. Announces the Appointment of Jon M. Foster as the Executive Vice President and Chief Operating Officer